Meanwhile, in RA patients, dopamine could activate the dopaminergic receptor (DR) and inhibit the release of IL-6, IL-8, and tumor necrosis factor (TNF) from synovial fibroblasts [61,62]. Here, CXCL8 is linked to rheumatoid arthritis.